Samuraciclib is a compound under investigation in a clinical trial for advanced malignancies. It is a small-molecule research compound with a complex heterocyclic structure containing multiple amine and alcohol functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Samuraciclib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
CT7001 hydrochloride
pharmaceutical raw material
4-hydroxy-1-methyl-7-phenoxy-3-Isoquinolinecarboxylic acid ethyl ester
research compound
Lithium 5-methyl-1,3,4-thiadiazole-2-carboxylate
Research compound
2-(4-AMINOBENZYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID
research reagent
2-(8-Bromodibenzo[b,d]furan-4-yl)-4,6-diphenyl-1,3,5-triazine
research reagent
The international HS code for Samuraciclib (CAS 1805833-75-3) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(3R,4R)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol
YCVGLKWJKIKVBI-MJGOQNOKSA-N
CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC[C@H]4CCNC[C@@H]4O
Sourcing Samuraciclib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.